Clinical Trial Update: MLD10 in the Prevention of Migraine in Adults [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial update for MLD10 in preventing migraine in adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• MLD10

Snippet

Sponsor: Pharmalyte Solutions LLC | Conditions: Migraine | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-10-09